Total, n (%) | ALL (%) (n = 150) | AML (%) (n = 85) | p | |
---|---|---|---|---|
Age (months) | ||||
≤12 | 120 (51.1) | 82 (54.7) | 38 (44.7) | 0.14 |
13-24 | 115 (48.9) | 68 (45.3) | 47 (55.3) | |
Gender | ||||
Male | 131 (55.7) | 78 (52.0) | 53 (62.4) | 0.12 |
Female | 104 (44.3) | 72 (48.0) | 32 (37.6) | |
Skin colour | ||||
White | 139 (59.9) | 92 (61.7) | 47 (56.6) | 0.44 |
Non-White | 93 (40.1) | 57 (38.3) | 36 (43.4) | |
WBC (x10 9 /L) | ||||
≤50 | 106 (46.5) | 59 (40.4) | 47 (57.3) | 0.01 |
>50 | 122 (53.5) | 87 (59.6) | 35 (42.7) | |
Chromosomal alterations | ||||
MLL r | 102 (77.3) | 73 (78.5) | 29 (74.4) | 0.006 |
ETV6-RUNX1 | 7 (5.3) | 7 (7.5) | 0 (0.0) | |
Hyperdiploidy | 6 (4.5) | 6 (6.5) | 0 (0.0) | |
Others | 17 (12.9) | 7 (7.5)a | 10 (25.6)b | |
RAS c | ||||
Wild-type | 175 (74.5) | 105 (70.0) | 70 (82.4) | 0.03 |
Mutated | 60 (25.5) | 45 (30.0) | 15 (17.6) | |
BRAF | ||||
Wild-type | 124 (99.2) | 61 (100.0) | 63 (98.4) | 1.00 |
Mutated | 1 (0.8) | 0 (0.0) | 1 (1.6) | |
FLT3 | ||||
Wild-type | 148 (93.1) | 88 (91.7) | 60 (95.2) | 0.52 |
Mutated | 11 (6.9) | 8 (8.3) | 3 (4.8) | |
NQO1 (rs1800566) d | ||||
CC | 97 (54.2) | 67 (53.6) | 30 (55.6) | 0.91 |
CT | 70 (39.1) | 50 (40.0) | 20 (37.0) | |
TT | 12 (6.7) | 8 (6.4) | 4 (7.4) |